Log in

OTCMKTS:PHMMF - Pharma Mar Stock Price, Forecast & News

$2.58
+0.03 (+1.18 %)
(As of 12/6/2019 04:00 PM ET)
Today's Range
$2.58
Now: $2.58
$2.60
50-Day Range
$1.95
MA: $2.15
$2.55
52-Week Range
$1.21
Now: $2.58
$2.70
Volume1,195 shs
Average Volume3,667 shs
Market Capitalization$569.85 million
P/E RatioN/A
Dividend YieldN/A
Beta0.03
Pharma Mar, SA, a biopharmaceutical company, engages in the discovery and development of marine-derived anticancer drugs in Spain and internationally. The company operates through two segments, Biopharmaceuticals and Consumer Chemicals. It develops and commercializes Yondelis, an antitumor agent for the treatment of advanced soft tissue sarcomas and for relapsed ovarian cancer. Read More…

Industry, Sector and Symbol

Industry Private households
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:PHMMF
Previous SymbolNASDAQ:PHMMF
CUSIPN/A
CIKN/A
Phone34-91-846-6000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$200.26 million

Profitability

Miscellaneous

Employees599
Market Cap$569.85 million
Next Earnings DateN/A
OptionableNot Optionable

Receive PHMMF News and Ratings via Email

Sign-up to receive the latest news and ratings for PHMMF and its competitors with MarketBeat's FREE daily newsletter.


Pharma Mar (OTCMKTS:PHMMF) Frequently Asked Questions

What is Pharma Mar's stock symbol?

Pharma Mar trades on the OTCMKTS under the ticker symbol "PHMMF."

Has Pharma Mar been receiving favorable news coverage?

Media stories about PHMMF stock have been trending extremely negative recently, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Pharma Mar earned a media sentiment score of -4.2 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 2.0 out of 10, indicating that recent media coverage is very unlikely to have an effect on the stock's share price in the near future. View News Stories for Pharma Mar.

Who are some of Pharma Mar's key competitors?

What other stocks do shareholders of Pharma Mar own?

Who are Pharma Mar's key executives?

Pharma Mar's management team includes the folowing people:
  • Dr. José María Fernández Sousa-Faro Ph.D., Founder, Exec. Chairman, CEO & Pres
  • Mr. Pedro Fernández Puentes, Exec. Vice-Chairman
  • Mr. Juan Carlos-Torres Carretero, Founder (Age 70)
  • Ms. María Luisa de Francia Caballero, Chief Financial Officer
  • Mr. Pascal Besman, Chief Operating Officer

How do I buy shares of Pharma Mar?

Shares of PHMMF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Pharma Mar's stock price today?

One share of PHMMF stock can currently be purchased for approximately $2.58.

How big of a company is Pharma Mar?

Pharma Mar has a market capitalization of $569.85 million and generates $200.26 million in revenue each year. Pharma Mar employs 599 workers across the globe.View Additional Information About Pharma Mar.

What is Pharma Mar's official website?

The official website for Pharma Mar is http://www.pharmamar.com/.

How can I contact Pharma Mar?

Pharma Mar's mailing address is Avda. De los Reyes 1 Pol. Ind. La Mina, Madrid U3, 28770. The company can be reached via phone at 34-91-846-6000.


MarketBeat Community Rating for Pharma Mar (OTCMKTS PHMMF)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  187 (Vote Outperform)
Underperform Votes:  208 (Vote Underperform)
Total Votes:  395
MarketBeat's community ratings are surveys of what our community members think about Pharma Mar and other stocks. Vote "Outperform" if you believe PHMMF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PHMMF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/7/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel